Resolute Financial, LLC Gsk PLC Transaction History

Resolute Financial, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$42.05 - $47.77 $3,532 - $4,012	84 Added 1.28%	6,637 $289,000
Q1 2022 Apr 15, 2022	BUY	$40.23 - $47.74 $2,936 - $3,485	73 Added 1.13%	6,553 $285,000
Q4 2021 Feb 15, 2022	BUY	$38.88 - $45.31 $251,942 - $293,608	6,480 New	6,480 $286,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Resolute Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Resolute Financial, LLC with notifications on news.